Roka Bioscience (ROKA) Reports Q3 Loss of $5.39/Share

Roka Bioscience (NASDAQ: ROKA) reported Q3 EPS of ($5.39), versus ($4.91) reported last year. Revenue for the quarter came in at $1.9 million, versus $1.5 million reported last year.

For earnings history and earnings-related data on Roka Bioscience (ROKA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BMO starts chip stocks coverage: Here are its preferred picks
• Morgan Stanley course-corrects their semiconductor equipment outlook on demand